最終更新日：2025/12/08
After reviewing the test results, the oncology team recommended mirvetuximab soravtansine for the patient's recurrent Fallopian tube cancer.
正解を見る
After reviewing the test results, the oncology team recommended mirvetuximab soravtansine for the patient's recurrent Fallopian tube cancer.
音声機能が動作しない場合はこちらをご確認ください
編集履歴（0）
